Related Experiment Videos
Neuroimaging in Alzheimer's disease
1Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston.
The Psychiatric Clinics of North America
|June 1, 1991
Summary
This review covers recent neuroimaging in Alzheimer's disease (AD). It details advanced techniques like MRI and PET scans for diagnosing and understanding AD progression.
Area of Science:
- Neurology
- Radiology
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
- Accurate diagnosis and understanding of AD pathology are crucial.
Purpose of the Study:
- To review recent neuroimaging studies in Alzheimer's disease patients.
- To discuss the application of various neuroimaging modalities in AD research and clinical practice.
Main Methods:
- Computerized Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Positron Emission Tomography (PET)
- Single-Photon Emission Computerized Tomography (SPECT)
Main Results:
- Neuroimaging plays a vital role in the early detection and differential diagnosis of AD.
- Different modalities offer unique insights into brain structure, function, and molecular changes in AD.
- Advances in neuroimaging techniques enhance the ability to monitor disease progression and treatment response.
Conclusions:
- Neuroimaging is indispensable for Alzheimer's disease research and clinical management.
- Continued development of imaging technologies promises improved diagnostic accuracy and therapeutic strategies for AD.